NOVOLI - Dai piatti tipici, recuperati dalla tradizione e rinnovati, all’ormai famoso caffè in ghiaccio promosso da Quarta Caffè: il Salento promuove le sue ...

Calze della Befana fai da te, regali simbolici e dettagli speciali: idee per vivere questa tradizione con più creatività e ...

Moderna has rallied ~23%, but I maintain a 'Sell' and 'market underperform' rating due to deteriorating fundamentals. MRNA’s recent rally is driven by improved liquidity, cost discipline, and a $1.5 ...

Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research into a potential bird flu mRNA vaccine, helping to recover some of the ...

Dec 18 (Reuters) - Moderna will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental bird flu vaccine, the U.S. drugmaker ‌said on Thursday.

Shares of Moderna, Inc. (NASDAQ: MRNA) are falling Thursday. The Massachusetts-based biotech company made two significant announcements regarding its finances and business strategy. What To Know: ...

Nov 20 (Reuters) - Moderna (MRNA.O), opens new tab said on Thursday it secured a five-year loan of $1.5 billion from Ares Management (ARES.N), opens new tab, as it targets up to 10% revenue growth ...

Rustica is coming home — at least for co-owner Mike DeCamp. On Friday, the Minneapolis bakery and cafe opens its newest location in downtown Wayzata, a few blocks from where DeCamp grew up. “I like ...

Moderna Inc. shares rose after the company posted a narrower third-quarter loss than Wall Street expected, a sign that its cost-cutting measures are helping offset the decline of its Covid business.

Mast interviewed more than two dozen former and current Moderna employees, along with analysts, rival executives, investors, and experts in mRNA and vaccines to understand how the company arrived at ...

Moderna’s efforts to advance its cancer pipeline “make sense” against the backdrop of a more skeptical U.S. government attitude toward infectious disease vaccines, the company’s oncology chief told ...